Early trial results suggest that prostatic artery embolization (PAE) is a safe and effective treatment for benign prostatic hyperplasia (BPH), according to findings published online ahead of print in the Journal of Vascular and Interventional Radiology.
The trial, by Sandeep Bagla, MD, of Inova Alexandria Hospital in Alexandria, Va., and colleagues, reported findings from 20 BPH patients who underwent PAE. Embolization was technically successful in 18 (90%) and clinical success was observed in 19 (95%) at one month, with average American Urological Association symptom score improvements of 10.8 points at one month, 12.1 points at three months, and 9.8 points at six months. No minor or major complications were reported.
“Unsuccessful embolizations were secondary to atherosclerotic occlusion of prostatic arteries,” the authors noted.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.